What is CVE-2023-51698?

CVE-2023-51698 is a critical-severity vulnerability in Mate-desktop Atril, classified under OS Command Injection. CVSS score: 9.6/10. Published 2024-01-12.

How severe is CVE-2023-51698?

Critical severity. CVSS v3 base score is 9.6 out of 10.

Is CVE-2023-51698 known to be exploited?

1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.

RCE in Mate-desktop Atril

CVE-2023-51698

Atril is a simple multi-page document viewer. Atril is vulnerable to a critical Command Injection Vulnerability. This vulnerability gives the attacker immediate access to the target system when the target user opens a crafted document or c…

Vulnerability class: Command Injection (OS Command Injection)

EPSS: 0.020 (84.0th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 9.6 (Critical). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:L.

Affected products

Mate-desktop Atril — versions <= 1.26.3

Weakness classification (CWE)

CWE-78 — OS Command Injection

Public proof-of-concept exploits

febinrev/atril_

References

Frequently asked questions

What is CVE-2023-51698?: CVE-2023-51698 is a critical-severity vulnerability in Mate-desktop Atril, classified under OS Command Injection. CVSS score: 9.6/10. Published 2024-01-12.
How severe is CVE-2023-51698?: Critical severity. CVSS v3 base score is 9.6 out of 10.
Is CVE-2023-51698 known to be exploited?: 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.